000 01267 a2200349 4500
005 20250515050926.0
264 0 _c20070104
008 200701s 0 0 eng d
022 _a1054-3406
024 7 _a10.1080/10543400600825645
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJung, Sin-Ho
245 0 0 _aP-value calculation for multistage phase II cancer clinical trials.
_h[electronic resource]
260 _bJournal of biopharmaceutical statistics
_c2006
300 _a765-75; discussion 777-83 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlgorithms
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aClinical Trials, Phase II as Topic
_xstatistics & numerical data
650 0 4 _aEndpoint Determination
650 0 4 _aHumans
650 0 4 _aLikelihood Functions
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aResearch Design
650 0 4 _aStochastic Processes
650 0 4 _aTreatment Outcome
700 1 _aOwzar, Kouros
700 1 _aGeorge, Stephen L
700 1 _aLee, Taiyeong
773 0 _tJournal of biopharmaceutical statistics
_gvol. 16
_gno. 6
_gp. 765-75; discussion 777-83
856 4 0 _uhttps://doi.org/10.1080/10543400600825645
_zAvailable from publisher's website
999 _c16716746
_d16716746